Professional paper

https://doi.org/10.15836/ccar2016.202

Reaching the targets with perindopril: hypertension and beyond.

Alenka Kmecl ; Krka, d. d., Novo mesto, Slovenia
Breda Barbič-Žagar orcid.org/0000-0002-1173-7361 ; Krka, d. d., Novo mesto, Slovenia
Polona Knavs Vrhunec ; Krka, d. d., Novo mesto, Slovenia

Abstract

High blood pressure has been identified as the leading risk factor, among 67 studied, for death and disability. Blood pressure control is still far from what would be necessary to reduce the cardiovascular risk. The treatment of hypertensive patients remains a challenging issue in daily clinical practice. The reduction in cardiovascular events with perindopril supports the concept of cardiovascular protective effects of perindopril beyond blood pressure lowering. Effective blood pressure con- trol, as demonstrated in clinical studies with Krka’s perindopril and its sed-dose combinations with indapamide and amlodipine, together with good tolerability and convenient once-daily dosing, have a positive impact on patients’ adherence to the treatment – which is a crucial step towards reaching the blood pressure targets.

Keywords

perindopril; hypertension; blood pressure; efficacy; safety; adherence

Hrčak ID:

158330

URI

https://hrcak.srce.hr/158330

Publication date:

11.5.2016.

Article data in other languages: croatian

Visits: 2.085 *